Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma

Jinkwon Lee; Gyeonghwa Kim; Tae-Su Han; Eunsun Jung; Taesang Son; Kwangho Kim; Kiyoon Kwon; Yuna Roh; Tae Young Ryu; In Hwan Tae; Yunsang Kang; Byungheon Lee; Yu Rim Lee; Soo Young Park; Won Young Tak; Dae-Soo Kim; Mi-Young Son; Keun Hur; Hyun-Soo Cho

doi:10.1002/cac2.12536

Cancer Communications ›› 2024, Vol. 44 ›› Issue (6) :705 -709. DOI: 10.1002/cac2.12536

LETTER TO THE JOURNAL

Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma

Jinkwon Lee ¹^,²
, Gyeonghwa Kim ³
, Tae-Su Han ¹^,²^,⁴
, Eunsun Jung ¹
, Taesang Son ¹^,²
, Kwangho Kim ¹
, Kiyoon Kwon ¹
, Yuna Roh ¹^,²
, Tae Young Ryu ¹
, In Hwan Tae ¹
, Yunsang Kang ¹^,²
, Byungheon Lee ³
, Yu Rim Lee ⁵
, Soo Young Park ⁵
, Won Young Tak ⁵
, Dae-Soo Kim ¹^,²^,^†
, Mi-Young Son ¹^,²^,⁴^,^†
, Keun Hur ³^,⁶^,^†
, Hyun-Soo Cho ¹^,²^,⁴^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Jinkwon Lee, Gyeonghwa Kim, Tae-Su Han, Eunsun Jung, Taesang Son, Kwangho Kim, Kiyoon Kwon, Yuna Roh, Tae Young Ryu, In Hwan Tae, Yunsang Kang, Byungheon Lee, Yu Rim Lee, Soo Young Park, Won Young Tak, Dae-Soo Kim, Mi-Young Son, Keun Hur, Hyun-Soo Cho. Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma. Cancer Communications, 2024, 44(6): 705-709 DOI:10.1002/cac2.12536

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

[2]	Gao X, Wang X, Zhang S. Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma. Biosci Rep. 2018;38(6):BSR20181441.

[3]	Chen W, Xiao W, Zhang K, Yin X, Lai J, Liang L, et al. Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence Sci Rep. 2016;6:22976.

[4]	Liu X, Xu X, Pan B, He B, Chen X, Zeng K, et al. Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer. J Cancer. 2019;10(1):43–50.

[5]	Wu Y, Wei J, Zhang W, Xie M, Wang X, Xu J. Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma. Onco Targets Ther. 2020;13:7809–18.

[6]	Wang Q, Wang G, Niu L, Zhao S, Li J, Zhang Z, et al. Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. J Oncol. 2021;2021:6617700.

[7]	Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M, Samadian M. A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion. Front Mol Biosci. 2021;8:763338.

[8]	Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem. 2022;123(3):506–31.

[9]	Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, et al. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. BMC Cancer. 2021;21(1):48.